Hand, foot, and mouth disease in China, 2008–12: an epidemiological study  Weijia Xing, PhD, Qiaohong Liao, MD, Cécile Viboud, PhD, Jing Zhang, MD, Junling.

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies  Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.
Volume 376, Issue 9755, Pages (November 2010)
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Volume 389, Issue 10076, Pages (April 2017)
Volume 382, Issue 9887, Pages (July 2013)
Seasonal synchrony in incidences of common infectious diagnoses in early childhood among neighbouring regions  TienYu Owen Yang, Wan-Ting Huang, Mei-Huei.
Eric P.F. Chow, David P. Wilson, Lei Zhang 
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
Volume 5, Issue 4, Pages (April 2006)
Controlling Ebola: key role of Ebola treatment centres
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study  Isaac I.
John N Nkengasong, Philip Onyebujoh  The Lancet 
Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis  Dr Steven E Bellan, PhD, Juliet.
Volume 392, Issue 10145, Pages (August 2018)
Underestimate of annual malaria imports to Canada – Author reply
Ebola superspreading The Lancet Infectious Diseases
Andrea Ganna, PhD, Prof Erik Ingelsson, MD  The Lancet 
Volume 366, Issue 9499, Pages (November 2005)
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
Lauren M Gardner, Nan Chen, Sahotra Sarkar 
Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical.
Ebola: worldwide dissemination risk and response priorities
Changing trends of neglected tropical diseases in China
Volume 381, Issue 9882, Pages (June 2013)
Cholera epidemic in Yemen, 2016–18: an analysis of surveillance data
J. Lu, H. Zeng, H. Zheng, L. Yi, X. Guo, L. Liu, L. Sun, X. Tan, H
Requirements for global elimination of hepatitis B: a modelling study
From Static to Dynamic Risk Prediction: Time Is Everything
Volume 391, Issue 10121, Pages (February 2018)
Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report  Emily Kainne Dokubo, MD, Annika Wendland, MPH, Suzanne.
Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 
Global reduction in measles mortality
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study  Weijia Xing, PhD, Qiaohong Liao, MD, Cécile Viboud, PhD, Jing Zhang, MD, Junling.
Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study  Ousmane Faye, PhD, Pierre-Yves Boëlle,
Challenges to eliminate rabies virus infection in China by 2020
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Resuscitation at birth and cognition at 8 years of age: a cohort study
Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study  Jue Liu, PhD, Shikun Zhang, MD,
Marshall Burke, PhD, Sam Heft-Neal, PhD, Dr Eran Bendavid, MD 
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis  Elima Jedy-Agba, MD, Valerie McCormack, PhD, Prof Clement.
Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance.
J. Du, X. Wang, Y. Hu, Z. Li, Y. Li, S. Sun, F. Yang, Q. Jin 
Cold water immersion: sudden death and prolonged survival
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Disparities in mortality among 25–44-year-olds in England: a longitudinal, population- based study  Prof Evangelos Kontopantelis, PhD, Prof Iain Buchan,
Hsin-Fang Li, PhD, YingXing Wu, MD, Mansen Wang, PhD, Gary L
One Health strategies for rabies control in rural areas of China
Volume 85, Issue 4, Pages (February 2015)
Volume 380, Issue 9840, Pages (August 2012)
Age and year trend of hand, foot and mouth disease (HFMD) symptomatic infection from the Incidence rate model (submodel 2). Age and year trend of hand,
Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association.
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study  Paul J Birrell, PhD, Prof O Noel Gill, FFPH, Valerie.
Errata The Lancet Infectious Diseases
Growth faltering in rural Gambian children after four decades of interventions: a retrospective cohort study  Helen M Nabwera, BM, Anthony J Fulford,
Volume 393, Issue 10172, Pages (February 2019)
Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis  Joseph A Lewnard, BA, Martial L Ndeffo Mbah,
Volume 375, Issue 9722, Pages (April 2010)
Volume 383, Issue 9921, Pages (March 2014)
Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration.
GBD 2016 estimates problematic for South Africa
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study  Michael A Irvine, PhD, Wilma A Stolk, PhD, Morgan.
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Timothy D. O'Hara, Ashley A. Rowden, Nicholas J. Bax  Current Biology 
Volume 382, Issue 9887, Pages (July 2013)
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials  Andrew Clark, PhD, Kevin van Zandvoort,
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling  Gwenan M Knight, PhD, C Finn McQuaid,
Presentation transcript:

Hand, foot, and mouth disease in China, 2008–12: an epidemiological study  Weijia Xing, PhD, Qiaohong Liao, MD, Cécile Viboud, PhD, Jing Zhang, MD, Junling Sun, PhD, Joseph T Wu, PhD, Zhaorui Chang, MD, Fengfeng Liu, MD, Vicky J Fang, MPhil, Yingdong Zheng, PhD, Benjamin J Cowling, PhD, Jay K Varma, MD, Prof Jeremy J Farrar, PhD, Prof Gabriel M Leung, MD, Dr Hongjie Yu, PhD  The Lancet Infectious Diseases  Volume 14, Issue 4, Pages 308-318 (April 2014) DOI: 10.1016/S1473-3099(13)70342-6 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Proportions of enterovirus serotypes in laboratory-confirmed cases of hand, foot, and mouth disease by clinical severity in China, 2008–12 (A) Based on mild cases. (B) Based on severe cases who survived. (C) Based on fatal cases. EV71=enterovirus 71. CV-A16=Coxsackie virus A16. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Age distribution and clinical severity of probable and laboratory-confirmed cases of hand, foot, and mouth disease in China, 2008–12 (A) Age distribution of probable and laboratory-confirmed cases. (B) Risk of fatality in cases by age group and serotype of virus. (C) Risk of severe illness in cases by age group and serotype of virus. (D) Risk of fatality in severe cases by age group and serotype of virus. We calculated severity estimates in (B)–(D) by extrapolating the serotype distribution in test-positive cases to untested and test-negative cases. The number of mild cases with serotype X (EV71, CV-A16, or other enteroviruses) was estimated to be number of mild cases test-positive for serotype X divided by number of test-positive mild cases times number of mild cases; severe cases were similarly analysed. Results were only similar if the 2010–12 or 2012 data were used (appendix pp 20, 21). EV71=enterovirus 71. CV-A16=Coxsackie virus A16. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Estimates of onset-to-diagnosis, onset-to-death, and diagnosis-to-death distributions of probable and laboratory-confirmed cases of hand, foot, and mouth disease in China, 2008–12 (A) Onset-to-diagnosis distribution by serotype of virus (n=7 200 092). (B) Onset-to-death distribution by serotype of virus (n=2457). (C) Diagnosis-to-death distribution by serotype of virus (n=2457). Some intervals are negative because diagnosis was done after death. EV71=enterovirus 71. CV-A16=Coxsackie virus A16. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Heat map of surveillance data for hand, foot, and mouth disease by Chinese province, 2008–12 (A) Time series of weekly probable and laboratory-confirmed cases of HFMD, standardised by the number of annual cases. (B) Seasonal distribution of cases of HFMD, plotted as the median value of proportion of cases in each week of the year from 2008 to 2012. For (A) and (B), the provinces were ordered by latitude from northermost (top) to southernmost (bottom). (C) Number of cases of HFMD by week of illness onset. The insert is a superposition of the number of cases without probable cases of HFMD by week of illness onset. HFMD=hand, foot, and mouth disease. EV71=enterovirus 71. CV-A16=Coxsackie virus A16. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Latitudinal gradients in periodicity of hand, foot, and mouth disease (A) Amplitude of the annual periodicity. (B) Amplitude of the semiannual periodicity. (C) Contribution of the semiannual periodicity, measured by the ratio of the amplitude of the semiannual periodicity to the sum of the amplitudes of annual and semiannual periodicities (higher ratio suggests a stronger semiannual periodicity). Symbol size is proportional to the number of cases in each province. Black solid lines represent linear regression fit (regression weighted by mean annual number of cases of hand, foot, and mouth disease). p values are given on the graphs. Colours represent different climatic zones (black=cold-temperate, blue=mid-temperate, green=warm-temperate, red=subtropical, turquoise=tropical). The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Periodicity and peak timing of hand, foot, and mouth disease epidemics in China (A) Amplitude of the annual cycle from pale red (low) to red (high). (B) Importance of the semiannual periodicity, measured by the ratio of the amplitude of the semiannual cycle to the sum of the amplitudes of annual and semiannual cycles. Pale green shows strongly annual epidemics; dark green shows dominant semiannual activity. (C) Timing of primary annual hand, foot, and mouth disease peak, in weeks from Jan 1. Timing is colour coded from pale blue to dark blue. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 7 Hand, foot, and mouth disease epidemiological regions and predictors (A) Epidemiological regions based on hierarchical clustering, identified with the Euclidian distance between weekly standardised hand, foot, and mouth disease time series. Provinces are colour-coded by climatic region (black=cold-temperate, blue=mid-temperate, green= warm temperate, red=subtropical, turquoise=tropical). (B) Map of the two epidemiological regions identified in (A). (C) Climate predictors of the two main clusters identified in (A), based on stepwise discriminant analysis. The Lancet Infectious Diseases 2014 14, 308-318DOI: (10.1016/S1473-3099(13)70342-6) Copyright © 2014 Elsevier Ltd Terms and Conditions